Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Neurotoxicity Research|April 24, 2007
The 6-hydroxydopamine model of Parkinson's diseaseNicola Simola, Micaela Morelli, Anna R Carta
Frontiers in Neuroscience|May 17, 2021
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?Ezio Carboni, Anna R Carta, Elena Carboni, et al.
Synapse (New York, N.Y.)|April 16, 2002
Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated ratsAnna R Carta, Annalisa Pinna, Omar Cauli, et al.
Progress in Brain Research|April 6, 2020
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applicationsKatarzyna Z Kuter, M Angela Cenci, Anna R Carta
Addiction Biology|December 19, 2019
Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving ratsDragana Jadzic, Valentina Bassareo, Anna R Carta, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 15, 2024
Adolescent stress differentially modifies dopamine and norepinephrine release in the medial prefrontal cortex of adult ratsEzio Carboni, Marcello Ibba, Elena Carboni, et al.
Neurology|December 10, 2003
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated ratsAnna R Carta, Annalisa Pinna, Elisabetta Tronci, et al.
Experimental Neurology|May 11, 2010
Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expressionAnna R Carta, Lucia Frau, Annalisa Pinna, et al.
International Journal of Molecular Sciences|November 25, 2023
Genetic and Molecular Regulations of Neuronal ActivityMarcella Reale, Cesar Borlongan, Anna R Carta, et al.
Progress in Neurobiology|April 25, 2016
Microglial phenotypes in Parkinson's disease and animal models of the diseaseValerie Joers, Malú G Tansey, Giovanna Mulas, et al.
Pageof 6